A multi-institutional study of malignancies after heart transplantation and a comparison with the general United States population

Journal of Heart and Lung Transplantation

Volumn 33, Issue 5, 2014, Pages 478-485

  Higgins, Robert S ^a   Brown, Robert N ^b   Chang, Patricia P ^c   Starling, Randall C ^d   Ewald, Gregory A ^e   Tallaj, Jose A ^b   Kirklin, James K ^f   George, James F ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NONE

Author keywords

hazard; heart transplantation; lung cancer; lymphoma; malignancy; multi institutional studies; statistics

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; AGE DISTRIBUTION; ARTICLE; BLADDER CANCER; BONE CANCER; BREAST CARCINOMA; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CARDIAC GRAFT REJECTION; COLON CANCER; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART GRAFT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CANCER; LEUKEMIA; LUNG CARCINOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MULTICENTER STUDY; OVARY CANCER; POPULATION; POSTOPERATIVE COMPLICATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CARCINOMA; SMOKING; SURVIVAL RATE; TESTIS CANCER; THYROID CANCER; UNITED STATES; UTERINE CERVIX CANCER; ADOLESCENT; CANCER REGISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; EPIDEMIOLOGY; FORECASTING; HEART TRANSPLANTATION; INCIDENCE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDY; RISK FACTOR; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; FOLLOW-UP STUDIES; FORECASTING; HEART TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 84898815679     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.01.862     Document Type: Article

References (26)

1. M.G. Crespo-Leiro, A. Villa-Arranz, and N. Manito-Lorite et al. Lung cancer after heart transplantation: results from a large multicenter registry Am J Transplant 11 2011 1035 1040
2. Y. Jiang, P.J. Villeneuve, A. Wielgosz, D.E. Schaubel, S.S. Fenton, and Y. Mao The incidence of cancer in a population-based cohort of Canadian heart transplant recipients Am J Transplant 10 2010 637 645
3. D. Collett, L. Mumford, N.R. Banner, J. Neuberger, and C. Watson Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit Am J Transplant 10 2010 1889 1896
4. T. Yagdi, L. Sharples, S. Tsui, S. Large, and J. Parameshwar Malignancy after heart transplantation: analysis of 24-year experience at a single center J Card Surg 24 2009 572 579
5. M.G. Crespo-Leiro, L. Alonso-Pulpon, and J.A. Vazquez de Prada et al. Malignancy after heart transplantation: incidence, prognosis and risk factors Am J Transplant 8 2008 1031 1039
6. N. Shiba, M.C. Chan, B.W. Kwok, H.A. Valantine, R.C. Robbins, and S.A. Hunt Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience J Heart Lung Transplant 23 2004 155 164
7. J.G. Krikorian, J.L. Anderson, C.P. Bieber, I. Penn, and E.B. Stinson Malignant neoplasms following cardiac transplantation JAMA 240 1978 639 643
8. R. Chinnock, S.A. Webber, A.I. Dipchand, R.N. Brown, and J.F. George Pediatric Heart Transplant Study. A 16-year multi-institutional study of the role of age and EBV status on PTLD incidence among pediatric heart transplant recipients Am J Transplant 12 2012 3061 3068
9. E. Oechslin, W. Kiowski, J. Schneider, F. Follath, M. Turina, and A. Gallino Pretransplant malignancy in candidates and posttransplant malignancy in recipients of cardiac transplantation Ann Oncol 7 1996 1059 1063
10. M. Garlicki, K. Wierzbicki, and P. Przybylowski et al. The incidence of malignancy in heart transplant recipients Ann Transplant 3 1998 41 47
11. L. Kellerman, A. Neugut, B. Burke, and D. Mancini Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population Am J Cardiol 103 2009 562 566
12. R.C. Bourge, D.C. Naftel, and M.R. Costanzo-Nordin et al. Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group J Heart Lung Transplant 12 1993 549 562
13. C. Chin, D.C. Naftel, and T.P. Singh et al. Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience J Heart Lung Transplant 23 2004 178 185
14. M.R. Costanzo, D.C. Naftel, and M.R. Pritzker et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database J Heart Lung Transplant 17 1998 744 753
15. J.F. George, S.V. Pamboukian, and J.A. Tallaj et al. Balancing rejection and infection with respect to age, race, and gender: clues acquired from 17 years of cardiac transplantation data J Heart Lung Transplant 29 2010 966 972
16. J.F. George, D.O. Taylor, and E.D. Blume et al. Minimizing infection and rejection death: Clues acquired from 19 years of multi-institutional cardiac transplantation data J Heart Lung Transplant 30 2011 151 157
17. J. Jarcho, D.C. Naftel, and T.W. Shroyer et al. Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group J Heart Lung Transplant 13 1994 583 595 discussion: 595-6
18. E.H. Blackstone, D.C. Naftel, and M.E. Turner The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information J. Am. Statistical Assoc 81 1986 615 624
19. K. Potaris, B. Radovancevic, and C.D. Thomas et al. Lung cancer after heart transplantation: a 17-year experience Ann Thorac Surg 79 2005 980 983
20. A. Espana, M.A. Martinez-Gonzalez, M. Garcia-Granero, I. Sanchez-Carpintero, G. Rabago, and J. Herreros A prospective study of incident nonmelanoma skin cancer in heart transplant recipients J Invest Dermatol 115 2000 1158 1160
21. G. Tessari, L. Naldi, and L. Boschiero et al. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study Arch Dermatol 146 2010 294 299
22. M.A. Bingler, B. Feingold, and S.A. Miller et al. Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children Am J Transplant 8 2008 442 445
23. G. Opelz, V. Daniel, C. Naujokat, and B. Dohler Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma Transplantation 88 2009 962 967
24. C. Manlhiot, S.M. Pollock-Barziv, and C. Holmes et al. Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients J Heart Lung Transplant 29 2010 648 657
25. S.A. Webber, D.C. Naftel, and F.J. Fricker et al. Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study Lancet 367 2006 233 239
26. J. Stehlick, L.B. Edwards, and A.Y. Kucheryavaya et al. The registry of the International Society for Heart and Lung Transplantation: Twenty-seventh official adult heart transplant report-2010 J Heart Lung Transplant 29 2010 1089 1103